Elsevier

Clinics in Liver Disease

Volume 20, Issue 3, August 2016, Pages 521-534
Clinics in Liver Disease

Alcoholic Liver Disease and Liver Transplantation

https://doi.org/10.1016/j.cld.2016.02.009Get rights and content

Section snippets

Key points

  • Excessive alcohol use is a common health care problem worldwide and is associated with significant morbidity and mortality.

  • Alcoholic liver disease represents the second most frequent indication for liver transplantation in North America and Europe.

  • The pretransplant evaluation of patients with alcoholic liver disease should aim at identifying those at high risk for posttransplant relapse of alcohol use disorder, as return to excessive drinking can be deleterious to graft and patient survival.

Epidemiology of alcohol use and alcoholic liver disease

Chronic excessive alcohol use is a major cause of preventable morbidity and mortality around the world. The World Health Organization (WHO) estimates that approximately 3.3 million deaths worldwide in 2012 were associated with alcohol misuse.1 Not only does chronic alcohol misuse lead to organ damage, it can also lead to increased risk of accidents and violence resulting in morbidity and mortality. The negative effects of alcohol use disproportionately affect the young.

Data from WHO show 9% of

Liver transplantation and alcoholic liver disease

Alcoholic liver disease is a major indication for liver transplantation worldwide. In the United States and Europe, alcoholic liver cirrhosis is the second most common indication for liver transplantation, behind only chronic HCV. Alcoholic liver disease accounts for approximately 40% of primary liver transplants in Europe, and approximately 20% in the United States.16, 17, 18

In a recent analysis of the United Network for Organ Sharing database in the United States from 1987 to 2013, the

Alcoholic liver disease in the pretransplant period

Patients suffering from end-stage alcoholic liver disease who require liver transplantation present a special challenge to the transplant teams, as they have a high prevalence of alcohol-related comorbidities, such as protein-energy malnutrition, chronic anemia, neurologic disorders, kidney dysfunction, heart disease, and psychiatric comorbidities, including substance abuse.19, 20 The risk of relapse of alcohol use disorder following liver transplantation, with potential associated liver

Posttransplant outcomes in alcoholic liver disease

Survival in patients transplanted for alcoholic liver disease is comparable to that of other etiologies, and even better than the long-term survival observed in patients transplanted for HCV.43 In large transplant registries from Europe and the United States, the 1-year, 3-year, and 5-year patient survival ranges from 81% to 92%, 78% to 86%, and 73% to 86%, respectively.16, 17 However, emerging data suggest patients with alcoholic liver disease with posttransplant relapses have a reduced

Liver transplantation in alcoholic hepatitis

AH is a distinct clinical syndrome seen in patients with chronic excessive alcohol use characterized by worsening jaundice, mild to moderate elevation in liver enzymes, coagulopathy, and hepatic encephalopathy. At times it can present as acute-on-chronic liver failure.61, 62

AH has significant morbidity and mortality, as documented both in Europe and the United States.63, 64 In the United States, there were 57,000 hospitalizations for AH in 2007, accounting for 0.7% of all admissions with an

Summary

Excessive chronic alcohol consumption is a common health care problem around the world, with significant morbidity and mortality. End-stage liver disease secondary to alcoholic cirrhosis is the second most frequent cause for liver transplantation in the United States and Europe. Posttransplant outcomes for most patients with alcoholic liver disease are comparable to those of other etiologies; however, patients with alcoholic liver disease have increased graft loss and mortality if they return

First page preview

First page preview
Click to open first page preview

References (75)

  • A.K. Singal et al.

    Nutrition in alcoholic liver disease

    Clin Liver Dis

    (2012)
  • J.H. Hoofnagle et al.

    Liver transplantation for alcoholic liver disease: executive statement and recommendations. Summary of a National Institutes of Health workshop held December 6-7, 1996, Bethesda, Maryland

    Liver Transpl Surg

    (1997)
  • M.R. Lucey

    Issues in selection for and outcome of liver transplantation in patients with alcoholic liver disease

    Liver Transpl Surg

    (1997)
  • J.E. Everhart et al.

    Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States

    Liver Transpl Surg

    (1997)
  • A.J. Bathgate et al.

    Recommendations for alcohol-related liver disease

    Lancet

    (2006)
  • J.K. Rustad et al.

    Risk factors for alcohol relapse following orthotopic liver transplantation: a systematic review

    Psychosomatics

    (2015)
  • J.R. Maldonado et al.

    The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates

    Psychosomatics

    (2012)
  • P.J. Gaglio et al.

    Complications in patients with alcohol-associated liver disease who undergo liver transplantation

    Clin Liver Dis

    (2012)
  • S.E. Newton

    Recidivism and return to work posttransplant. Recipients with substance abuse histories

    J Subst Abuse Treat

    (1999)
  • A. DiMartini et al.

    Trajectories of alcohol consumption following liver transplantation

    Am J Transplant

    (2010)
  • S. Saigal et al.

    Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation

    Liver Transpl

    (2002)
  • K.D. Watt et al.

    Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study

    Am J Transplant

    (2010)
  • A.K. Singal et al.

    Alcoholic hepatitis: current challenges and future directions

    Clin Gastroenterol Hepatol

    (2014)
  • U. Sohail et al.

    Diagnosis and management of alcoholic hepatitis

    Clin Liver Dis

    (2012)
  • T.D. Sandahl et al.

    Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study

    J Hepatol

    (2011)
  • S. Tome et al.

    Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease

    J Hepatol

    (2002)
  • V. Perut et al.

    Might physicians be restricting access to liver transplantation for patients with alcoholic liver disease?

    J Hepatol

    (2009)
  • G. Stroh et al.

    Early liver transplantation for patients with acute alcoholic hepatitis: public views and the effects on organ donation

    Am J Transplant

    (2015)
  • WHO

    Global status report on alcohol and health 2014

    (2014)
  • CDC

    Alcohol related disease impact (ARDI)

    (2013)
  • European Association for the Study of Liver

    EASL clinical practical guidelines: management of alcoholic liver disease

    J Hepatol

    (2012)
  • G. Corrao et al.

    Trends of liver cirrhosis mortality in Europe, 1970-1989: age-period-cohort analysis and changing alcohol consumption

    Int J Epidemiol

    (1997)
  • D.A. Leon et al.

    Alcohol and Russian mortality: a continuing crisis

    Addiction

    (2009)
  • M. Ramstedt

    Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries

    Addiction

    (2001)
  • American Psychiatric Association

    Alcohol-related disorders

  • A.K. Singal et al.

    Evolving frequency and outcomes of liver transplantation based on etiology of liver disease

    Transplantation

    (2013)
  • M. Stepanova et al.

    The portrait of an adult liver transplant recipient in the United States from 1987 to 2013

    JAMA Intern Med

    (2014)
  • Cited by (15)

    • Liver Transplantation for Alcoholic Liver Disease: An Update

      2019, Clinics in Liver Disease
      Citation Excerpt :

      All these require monitoring and supplementation.19,21 Indications and contraindications for LT in patients with end-stage ALD are similar to those for other causes; however, there is an additional focus on selecting patients who are less likely to relapse into harmful alcohol use.13 Before referring a patient with end-stage liver disease for transplantation, even if their primary disease is not ALD, a detailed history of the patient’s alcohol and other substance use, and their consequences, is required.

    • Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States

      2017, Clinical Gastroenterology and Hepatology
      Citation Excerpt :

      Despite the stringent criteria involved in selecting reformed patients with alcohol-induced liver disease for LT, the number of registrants has increased steadily since 2009, tracking more steeply upward between 2014 and 2015, making it the leading indication for LT registrations among non-HCC registrants, surpassing HCV in 2015. Our data are consistent with a recent report showing that alcohol was a more common indication for LT than nonalcoholic fatty liver disease in 2014.26 When the listing indication of HCC registrants was replaced by the diagnosis of the underlying etiology of liver disease (Figure 1C), alcohol-induced liver disease was still the second leading cause among LT registrants after HCV, but has shown a trajectory of becoming the leading underlying etiology for LT listing, surpassing HCV in the next few years.

    View all citing articles on Scopus

    The authors have nothing to disclose.

    View full text